Culmination Bio integrates biological data with clinical, claims, and genomic information to enhance health care insights. This approach enables health care organizations to make data-driven decisions that improve patient outcomes and streamline care delivery.
Funding
$10M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AVMGFounders
Product
Problem
Healthcare organizations face challenges in leveraging complex biological data alongside clinical, claims, and genomic information to derive actionable insights. The lack of integrated, multi-dimensional datasets hinders the discovery of novel therapeutic targets, diagnostic opportunities, and optimized care process models. This limits the ability to make data-driven decisions that improve patient outcomes and streamline care delivery.
Solution
Culmination Bio offers the Culmination Intelligence Platform, a solution that integrates diverse, multi-dimensional, longitudinal clinical data with matched biospecimens, including omics-level data. This enriched, de-identified dataset serves as a powerful insight engine for medical research, health data analysis, and healthcare services. The platform enables novel discoveries by linking genomic, biological, health, and claims data. By leveraging longitudinal, multi-modal data across vast patient datasets, the platform facilitates a better understanding of the performance of diagnostics and therapeutics.
Target Audience
The primary target audience includes healthcare organizations, technology companies, and biopharmaceutical companies seeking to enhance their research and development efforts, improve patient care, and discover novel insights from complex healthcare data.
Features
- Longitudinal, multi-modal data integration across de-identified patient datasets
- Linked genomic, biological, health, and claims data for novel insights
- Millions of linked biospecimens with associated omics-level data generation (WGS, WTS, WES, proteomics)
- Identification of novel clinical insights, therapeutic targets, diagnostic opportunities, and care process models